IRadimed Corporation (NASDAQ:IRMD) Q1 2024 Earnings Call Transcript
Operator: Welcome to IRADIMED CORPORATION First Quarter of 2024 Financial Results Conference Call.
Iradimed Corp (IRMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nine Ten Partners Brian Bares, Russell Mollen, And James Bradshaw | 809,366 | $35,604,000 | +2% | 10.84% |
| 2. | Soleus Capital Guy Levy | 361,630 | $15,908,104 | -44% | 1.18% |
| 3. | Bares Capital Management Brian Bares | 279,000 | $12,273,210 | +1% | 0.48% |
| 4. | Millennium Management Israel Englander | 97,099 | $4,271,385 | -6% | 0% |
| 5. | Roubaix Capital Christopher Hillary | 50,307 | $2,213,005 | 1.39% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.85 | 1,000 | 21,000 | 2018-03-16 | Filing | ||
| $8.65 | 5,000 | Large Shareholder, Officer, Director | 20,000 | 2017-02-09 | Filing | |
| $8.55 | 5,000 | Large Shareholder, Officer, Director | 15,000 | 2017-02-08 | Filing | |
| $11.24 | 5,000 | Large Shareholder, Officer, Director | 10,000 | 2016-11-29 | Filing | |
| $10.46 | 5,000 | Large Shareholder, Officer, Director | 5,000 | 2016-11-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $43.37 | 1,947 | 18,053 | 2024-06-03 | Filing | ||
| $46.51 | 5,000 | 162,950 | 2023-12-27 | Filing | ||
| $46.00 | 5,000 | 167,950 | 2023-12-26 | Filing | ||
| $45.14 | 5,000 | 172,950 | 2023-12-19 | Filing | ||
| $44.08 | 5,000 | 177,950 | 2023-12-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 651,948 | $30,947,972 | 0% | |
| 2. | 426,875 | $20,263,756 | 0% | |
| 3. | 340,400 | $16,158,788 | 3.44% | |
| 4. | 223,612 | $10,614,862 | 0.64% | |
| 5. | 211,288 | $10,029,839 | 0.01% |
News See All
Should You Invest in IRadimed Corporation (IRMD)?
Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
IRadimed Corporation (NASDAQ:IRMD) Q4 2023 Earnings Call Transcript
IRadimed Corporation beats earnings expectations. Reported EPS is $0.39, expectations were $0.37.
IRadimed Corporation (NASDAQ:IRMD) Q3 2023 Earnings Call Transcript
Operator: Welcome to the IRadimed Corporation Third Quarter of 2023 Financial Results Conference Call.
IRadimed Corporation (NASDAQ:IRMD) Q1 2023 Earnings Call Transcript
Operator: Welcome to IRadimed Corporation First Quarter of the 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
IRadimed Corporation (NASDAQ:IRMD) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to IRadimed Corporation Fourth Quarter and Full Year 2022 Financial Results Conference Call. Currently, all participants are in a listen-only mode.
Hedge Funds Are Selling iRadimed Corporation (IRMD)
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious...
Is iRadimed Corporation (IRMD) A Good Stock To Buy Now?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Have Never Been This Bullish On iRadimed Corporation (IRMD)
In this article we will check out the progression of hedge fund sentiment towards iRadimed Corporation (NASDAQ:IRMD) and determine whether it is a good investment right now.
Hedge Funds Have Never Been More Bullish On iRadimed Corporation (IRMD)
A whopping number of 13F filings filed with U.S.
Billionaire Hedge Funds
